🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT02040714
Enrolling by invitation Observational

Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease

NCT02040714 · tracked via the Priya Life Science China tracker
Sponsor
Texas Scottish Rite Hospital for Children
Phase
Observational
Started
2012-08
Last updated
2025-05-06

Condition(s) studied

Legg Calve Perthes Disease

Investigational drug(s) / intervention(s)

Osteotomy + Long Term Non-Weight BearingOsteotomy + Short Term Non-Weight BearingNonoperative ObservationMultiple Epiphyseal Drilling

Osteotomy + Long Term Non-Weight Bearing: Surgical procedure that improves femoral head containment, plus a post-operative protocol that requires patient to maintain non-weight bearing for 6 months.

Osteotomy + Short Term Non-Weight Bearing: Surgical procedure that improves femoral head containment, plus a post-operative protocol that allows early return to function after 6 weeks of non-weight bearing.

Nonoperative Observation: Group will not undergo any surgical or invasive procedures during course of treatment.

Multiple Epiphyseal Drilling: Multiple epiphyseal drilling is a procedure that creates small holes in the femoral head growth plate to increase blood flow into the femoral head.

Study summary

Legg-Calvé-Perthes disease is a childhood hip disorder which is common enough to be a significant public health problem (affects 1 in 740 boys between ages 0-14), but uncommon enough to have a sufficient number of patients from a single institution to perform a definitive prospective study comparing the results of current treatments. The present study will establish a database of prospectively identified patients with Legg-Calvé-Perthes (LCP) Disease and collect information regarding their presentation, treatment, and outcomes in the course of receiving currently available treatments.

This study seeks to compare the outcomes of current treatments in the management of different age groups (ages 1-6, 6-8, 8-11, \>11) of patients with Perthes disease at two- and five-year followup and at skeletal maturity. For each age group, two to three common treatment regimens currently used by practicing pediatric orthopaedic surgeons will be compared. The intervention a patient receives is determined through physician treatment expertise, and is not pre-determined by the study.

Eligibility

Sex
ALL
Min age
1 Year
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria: * Diagnosed with Legg-Calvé-Perthes disease * Between age 1-18 * Patients with possible secondary femoral osteonecrosis if over the age of 11 due to trauma or corticosteroid therapy are also eligible. Exclusion Criteria: * Patients with previous surgical treatment on the affected hip

Primary outcome measure(s)

Trial sites (46)

FacilityCityRegionStatus
Children's Hospital of Alabama Birmingham Alabama
Children's Hospital of Los Angeles Los Angeles California
Kaiser Permanente Hospital Los Angeles California
Rady Children's Hospital California San Diego California
UCSF Benioff Children's Hospitals San Francisco California
Children's Hospital Colorado Aurora Colorado
Connecticut Children's Medical Center Hartford Connecticut
Alfred I. DuPont Hospital for Children of the Nemours Foundation Wilmington Delaware
Children's National Medical Center Washington D.C. District of Columbia
Children's Orthopaedics of Atlanta Atlanta Georgia
Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois
Johns Hopkins Baltimore Maryland
Children's Hospital Boston Boston Massachusetts
Mayo Clinic Rochester Minnesota
Gillette Children's Specialty Healthcare Saint Paul Minnesota
NYU Langone/Hospital for Joint Disease New York New York
New York Presbyterian Hospital (Columbia Campus) New York New York
Children's Hospital at Montefiore The Bronx New York
OrthoCarolina Charlotte North Carolina
Cincinnati Children's Hospital Medical Center Cincinnati Ohio
Nationwide Children's Hospital Columbus Ohio
Oklahoma University Health Science Center Oklahoma City Oklahoma
Oregon Health and Science University Portland Oregon
Children's Hospital of Philadelphia Philadelphia Pennsylvania
University of Tennessee-Campbell Clinic Germantown Tennessee
Texas Scottish Rite Hospital for Children Dallas Texas
Texas Children's Hospital Houston Texas
Seattle Children's Hospital Seattle Washington
Women and Children's Hospital of Adelaide Adelaide South Australia
Universidade de São Paulo São Paulo Brazil
Alberta Children's Hospital, Division of Paediatric Surgery Calgary Alberta
British Columbia Children's Hospital Vancouver British Columbia
Tianjin Hospital Pediatric Orthopedics Tianjin China
Children's Hospital Hamburg-Altona Hamburg Germany
Hospital of Schleswig-Holstein Lübeck Germany
University Hospital of Schleswig-Holstein (Campus Lubeck) Lübeck Germany
Kasturba Medical College (KMC), Manipal Udupi Karnataka
Children's Health Ireland at Temple Street Dublin Ireland
Oslo University Hospital Oslo Norway
Medical University of Lodz Lodz Poland

+ 6 more sites — see the full list on the official registry below.

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02040714 on ClinicalTrials.gov ↗ ← All trials in China